vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Vontier Corp (VNT). Click either name above to swap in a different company.
Vontier Corp is the larger business by last-quarter revenue ($808.5M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Vontier Corp runs the higher net margin — 15.3% vs 6.8%, a 8.5% gap on every dollar of revenue. On growth, Vontier Corp posted the faster year-over-year revenue change (4.1% vs -1.7%). Over the past eight quarters, Vontier Corp's revenue compounded faster (3.4% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Vontier Corporation is an industrial manufacturing company headquartered in Raleigh, North Carolina. It owns the brands Gilbarco Veeder-Root, Matco Tools and Teletrac Navman, including subsidiaries Hennessy Industries, Gasboy, and Global Traffic Technologies (GTT).
MD vs VNT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $808.5M |
| Net Profit | $33.7M | $123.5M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 18.9% |
| Net Margin | 6.8% | 15.3% |
| Revenue YoY | -1.7% | 4.1% |
| Net Profit YoY | 10.5% | 0.0% |
| EPS (diluted) | $0.40 | $0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $808.5M | ||
| Q3 25 | $492.9M | $752.5M | ||
| Q2 25 | $468.8M | $773.5M | ||
| Q1 25 | $458.4M | $741.1M | ||
| Q4 24 | $502.4M | $776.8M | ||
| Q3 24 | $511.2M | $750.0M | ||
| Q2 24 | $504.3M | $696.4M | ||
| Q1 24 | $495.1M | $755.8M |
| Q4 25 | $33.7M | $123.5M | ||
| Q3 25 | $71.7M | $102.8M | ||
| Q2 25 | $39.3M | $91.9M | ||
| Q1 25 | $20.7M | $87.9M | ||
| Q4 24 | $30.5M | $123.5M | ||
| Q3 24 | $19.4M | $91.8M | ||
| Q2 24 | $-153.0M | $70.1M | ||
| Q1 24 | $4.0M | $136.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 47.3% | ||
| Q2 25 | — | 47.9% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 47.2% | ||
| Q2 24 | — | 48.2% | ||
| Q1 24 | — | 49.2% |
| Q4 25 | 9.9% | 18.9% | ||
| Q3 25 | 13.8% | 18.9% | ||
| Q2 25 | 12.8% | 17.6% | ||
| Q1 25 | 7.0% | 17.6% | ||
| Q4 24 | 7.8% | 19.2% | ||
| Q3 24 | 6.6% | 17.5% | ||
| Q2 24 | -31.3% | 16.4% | ||
| Q1 24 | 3.2% | 18.8% |
| Q4 25 | 6.8% | 15.3% | ||
| Q3 25 | 14.5% | 13.7% | ||
| Q2 25 | 8.4% | 11.9% | ||
| Q1 25 | 4.5% | 11.9% | ||
| Q4 24 | 6.1% | 15.9% | ||
| Q3 24 | 3.8% | 12.2% | ||
| Q2 24 | -30.3% | 10.1% | ||
| Q1 24 | 0.8% | 18.1% |
| Q4 25 | $0.40 | $0.85 | ||
| Q3 25 | $0.84 | $0.70 | ||
| Q2 25 | $0.46 | $0.62 | ||
| Q1 25 | $0.24 | $0.59 | ||
| Q4 24 | $0.37 | $0.82 | ||
| Q3 24 | $0.23 | $0.60 | ||
| Q2 24 | $-1.84 | $0.45 | ||
| Q1 24 | $0.05 | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $492.2M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $1.2B |
| Total Assets | $2.2B | $4.4B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $492.2M | ||
| Q3 25 | $340.1M | $433.8M | ||
| Q2 25 | $224.7M | $364.2M | ||
| Q1 25 | $99.0M | $333.6M | ||
| Q4 24 | $229.9M | $356.4M | ||
| Q3 24 | $103.8M | $330.9M | ||
| Q2 24 | $19.4M | $331.3M | ||
| Q1 24 | $8.0M | $406.0M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.2B | ||
| Q3 25 | $890.7M | $1.2B | ||
| Q2 25 | $833.8M | $1.2B | ||
| Q1 25 | $789.2M | $1.1B | ||
| Q4 24 | $764.9M | $1.1B | ||
| Q3 24 | $732.5M | $1.0B | ||
| Q2 24 | $706.5M | $1.0B | ||
| Q1 24 | $856.2M | $984.9M |
| Q4 25 | $2.2B | $4.4B | ||
| Q3 25 | $2.2B | $4.4B | ||
| Q2 25 | $2.1B | $4.4B | ||
| Q1 25 | $2.0B | $4.3B | ||
| Q4 24 | $2.2B | $4.3B | ||
| Q3 24 | $2.1B | $4.3B | ||
| Q2 24 | $2.0B | $4.2B | ||
| Q1 24 | $2.2B | $4.3B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $190.1M |
| Free Cash FlowOCF − Capex | — | $174.8M |
| FCF MarginFCF / Revenue | — | 21.6% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.54× |
| TTM Free Cash FlowTrailing 4 quarters | — | $441.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $190.1M | ||
| Q3 25 | $137.3M | $110.5M | ||
| Q2 25 | $137.2M | $100.0M | ||
| Q1 25 | $-117.5M | $110.4M | ||
| Q4 24 | $133.0M | $168.1M | ||
| Q3 24 | $91.8M | $121.8M | ||
| Q2 24 | $107.0M | $46.1M | ||
| Q1 24 | $-125.2M | $91.5M |
| Q4 25 | — | $174.8M | ||
| Q3 25 | — | $90.3M | ||
| Q2 25 | — | $83.3M | ||
| Q1 25 | — | $92.7M | ||
| Q4 24 | — | $148.0M | ||
| Q3 24 | — | $103.2M | ||
| Q2 24 | — | $22.3M | ||
| Q1 24 | — | $71.3M |
| Q4 25 | — | 21.6% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | 10.8% | ||
| Q1 25 | — | 12.5% | ||
| Q4 24 | — | 19.1% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 9.4% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | 2.7% |
| Q4 25 | 3.39× | 1.54× | ||
| Q3 25 | 1.91× | 1.07× | ||
| Q2 25 | 3.49× | 1.09× | ||
| Q1 25 | -5.66× | 1.26× | ||
| Q4 24 | 4.36× | 1.36× | ||
| Q3 24 | 4.72× | 1.33× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | -31.03× | 0.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
VNT
| Environmental Fueling Solutions Segment | $387.5M | 48% |
| Services | $191.0M | 24% |
| Repair Solutions Segment | $144.5M | 18% |
| Other | $85.5M | 11% |
